Connect Biopharma Holdings (CNTB) Assets (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Assets of $60.1 million for Q1 2026, up 7.12% sequentially from $56.1 million in Q4 2025, and down 35.19% YoY from $92.7 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Assets (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Assets for 7 years, with the latest figure at $60.1 million in Q1 2026.
- Quarterly Assets fell 35.19% year-over-year to $60.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.1 million (down 35.19% YoY) and the FY2025 annual result came in at $56.1 million, down 44.64% from the prior year.
- Assets advanced to $60.1 million in Q1 2026 per CNTB's latest filing, from $56.1 million in the prior quarter.
- Over five years, Assets peaked at $234.7 million in Q2 2022 and troughed at $56.1 million in Q4 2025.
- A 5-year average of $114.3 million and a median of $101.3 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets dropped 16.32% in 2024, then sank 44.64% in 2025.
- Over 5 years, Assets stood at $170.4 million in 2022, then dropped by 25.25% to $127.4 million in 2023, then dropped by 20.48% to $101.3 million in 2024, then tumbled by 44.64% to $56.1 million in 2025, then advanced by 7.12% to $60.1 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $60.1 million, $56.1 million, and $67.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 43.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.47 Mn |
| Mar 31, 2026 | 60.07 Mn |
| Dec 31, 2025 | 56.08 Mn |
| Sep 30, 2025 | 67.36 Mn |
| Jun 30, 2025 | 82.73 Mn |
| Mar 31, 2025 | 92.69 Mn |
| Dec 31, 2024 | 101.28 Mn |
| Jun 30, 2024 | 120.57 Mn |
| Dec 31, 2023 | 127.38 Mn |
| Jun 30, 2023 | 144.08 Mn |
| Dec 31, 2022 | 170.40 Mn |
| Jun 30, 2022 | 234.70 Mn |
| Dec 31, 2021 | 290.24 Mn |
| Dec 31, 2020 | 163.70 Mn |